A Systematic Review of the Potential Effects of Lippia sidoides on Dental Plaque and Periodontal Diseases.
Ellen Lima de AssisFelipe Dantas SilveiraAlan Victor Araújo da PonteRômulo Rocha RegisPublished in: Planta medica (2021)
Lippia sidoides is a typical shrub from Brazil that has been used in traditional medicine. This is a systematic review on the effect of L. sidoides for controlling dental plaque, gingivitis, and periodontitis. A database search through May 2021 in Medline/PubMed, SCOPUS, BVS, and Web of Science identified 711 reports of which 17 met our inclusion criteria. Five randomized controlled trials and three animal studies were included that compared L. sidoides-based products (toothpaste, mouthrinse, and gel) to cetylpyridinium chloride, chlorhexidine, and placebo products. Among the human studies, a significant antiplaque effect after treatment with L. sidoides-based products was observed in three studies and an antigingivitis effect in two studies, similar to chlorhexidine-based products. One study found superior dental plaque reduction compared to cetylpyridinium chloride mouthrinse. Only one study testing a L. sidoides gel found no antiplaque effect. Among the animal studies, an L. sidoides mouthrinse significantly reduced calculus in two studies, inflammatory infiltrate in one study, and plaque bacteria and gingivitis in one study. An L. sidoides gel significantly reduced alveolar bone loss and inflammatory response in one study in which mice were submitted to ligature-induced periodontal disease. In general, L. sidoides-based products were effective in reducing dental plaque and calculus formation, as well as clinical signs of gingivitis. As most studies present methodological limitations, these results should be interpreted carefully. Further clinical trials with greater methodological accuracy and control of biases are necessary for the use of L. sidoides-based products in humans to be viable in clinical practice.
Keyphrases
- clinical trial
- inflammatory response
- coronary artery disease
- randomized controlled trial
- case control
- clinical practice
- emergency department
- metabolic syndrome
- type diabetes
- systematic review
- bone loss
- phase ii
- toll like receptor
- climate change
- lipopolysaccharide induced
- surgical site infection
- lps induced
- open label
- adverse drug
- drug induced
- phase iii